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Abstract
Non-contrast cardiac computed tomography in order to obtain the coronary artery calcium score has become an established diagnostic
procedure in the clinical setting, and is commonly employed in clinical and population-based research. This state-of-the-art review paper
highlights the potential gain in information that can be obtained from the non-contrast coronary calcium scans without any necessary
modifications to the scan protocol. This includes markers of cardio-metabolic health, such as the amount of epicardial fat and liver fat,
but also markers of general health including bone density and lung density. Finally, this paper addresses the importance of incidental
findings and of radiation exposure accompanying imaging with non-contrast cardiac computed tomography. Despite the fact that
coronary calcium scan protocols have been optimized for the visualization of coronary calcification in terms image quality and radiation
exposure, it is important for radiologists, cardiologists and medical specialists in the field of preventive medicine to acknowledge that
numerous additional markers of cardio-metabolic health and general health can be readily identified on a coronary calcium scan.
Key Points
• The coronary artery calcium score substantially increased the use of cardiac CT.
• Cardio-metabolic and general health markers may be derived without changes to the scan protocol.
• Those include epicardial fat, aortic valve calcifications, liver fat, bone density, and lung density.
• Clinicians must be aware of this potential additional yield from non-contrast cardiac CT.
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Abbreviations
ALARA As-low-as-reasonably-achievable
CACS Coronary artery calcium score
CT Computed tomography
ECG Electrocardiography
Introduction
Over the past decade, non-contrast cardiac computed tomogra-
phy (CT) has become an established diagnostic tool in clinical
practice. The main purpose of these coronary calcium scans is to
obtain the coronary artery calcium score (CACS) [1, 2], which is
associated with a graded increased risk of future coronary events,
heart failure and mortality [3–5], and even relates to dementia,
cancer and kidney disease [6, 7]. On the other hand, a negative or
zero CACS denotes a mid- to long-term risk of coronary events
that is close to zero [8, 9]. As such, the current ACC/AHA
guidelines on assessment of cardiovascular risk state that assess-
ment of CACS may be considered based on a large number of
observational studies: with a CACS of ≥ 300Agatston units (or ≥
75th percentile for age, sex and ethnicity) supporting an upward
revision in risk assessment [10]. A range of alternative ap-
proaches to application of CACS for risk stratification in primary
prevention has been proposed recently [11–13].
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Most clinical radiologists and cardiologists will be
aware of other cardiac imaging properties that can be
obtained from coronary calcium scans, such as large
myocardial scars or dimensions of the heart and the
thoracic aorta [14]. These can be assessed to detect
past-myocardial infarction, dilated cardiomyopathies,
atrial enlargement, aneurysms and pericardial effusion.
However, coronary calcium scans contain a wealth of
untapped information on other cardiovascular and non-
cardiovascular health parameters [15, 16]. It is important
for clinicians to be aware of the potential data on
cardio-metabolic and general health that can be obtained
from such scans without making any modifications to
the scan protocol (Table 1). Hence, the goal of this
review is to provide an overview of some of the most
apparent imaging markers related to cardio-metabolic
and general health. Additionally, we discuss potential
incidental findings and radiation exposure of coronary
calcium scans.
Markers of cardio-metabolic health
With the increasing focus on preventive medicine and the
accompanying demand for individual risk stratification, the
ability to calculate a patient’s risk of a clinical event relies
greatly on the accuracy and amount of the acquired informa-
tion. The coronary calcium scan can provide us with addition-
al information regarding the patient’s cardiovascular health
beyond the CACS. In the following paragraphs we address
several of these markers.
Coronary artery calcium volume and density
The Agatston-based CACS is a summary measure based on
the total volume and density of epicardial coronary calcifica-
tion into a single number ranging from 0 (i.e. the absence of
calcifications) to scores of several thousand indicating exten-
sive coronary atherosclerosis. However, more recent evidence
suggests that calcium volume and density each separately har-
bour additional information with regard to the risk of
subsequent clinical events [17–19]. Importantly, these mea-
sures of density and volume generally do not require addition-
al processing or calculation, as these can be provided by most
commercially available CACS scoring software. Moreover,
the number and the regional distribution of calcifications can
easily be visually assessed and provide additive predictive
information regarding the future risk of major coronary events
[20]. As a consequence, very recently a change in methodol-
ogy to assess coronary calcium scans was proposed in order to
incorporate this additional information into a new CACS [21].
Valvular calcification
Using the same software as is used to obtain the CACS, one
can quantitatively assess the burden of aortic valve calcifica-
tion (Fig. 1, blue) [22, 23] or mitral annular calcification in the
form of Agatston scores or volumes. The extent of aortic val-
vular calcification is a direct representation of degenerative
aortic valve stenosis [24] and is associated with adverse car-
diovascular outcomes and mortality [25, 26]. More specifical-
ly, recent evidence even highlighted that the load of aortic
valve calcification measured by CT provides incremental
prognostic value to predict aortic valve stenosis progression
and subsequent occurrence of clinical events [27]. Similarly,
mitral annular calcification, although less prevalent [28], was
found to be associated with CACS [29], and to increase the
risk of atrial fibrillation [30]. Additionally, progression of mi-
tral annular calcification are an important predictor underlying
left atrial abnormalities that predispose to atrial fibrillation
[31].
Epicardial fat
Epicardial fat is defined as the layer of metabolically ac-
tive adipose tissue that surrounds the myocardium and the
coronary arteries [32, 33]. Given this close anatomical
connection, changes in the amount of epicardial fat may
directly influence these structures. Larger amounts of epi-
cardial fat are associated with more extensive coronary
atherosclerosis [34–36], but also with direct arrhythmo-
genic effects on the myocardium in the form of an
Table 1 Overview of imaging
markers that can be derived from
a coronary calcium scan
Cardio-metabolic health General health
Coronary artery calcium (Agatston score, volume and density) Vertebral bone density
Aortic valve calcification (Agatston score, volume and density) Lung density
Mitral annular calcification (Agatston score, volume and density)
Dimensions of heart chambers and ascending aorta
Epicardial fat volume
Liver density
Pulmonary artery diameter
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increased risk of new-onset atrial fibrillation and greater
burden of atrial fibrillation [37, 38]. Due to rapid im-
provements in image-processing techniques it has become
possible to quantify the amount of epicardial fat on non-
contrast CT scans [39, 40]. These quantification methods
are robust and fully automatic, but have not yet reached
the same level of usability as commercially available soft-
ware packages for calcium scoring. However, given the
recent insights in the clinical importance of epicardial
fat, implementation of tools for epicardial fat quantifica-
tion in such software packages are expected.
Liver density
In most instances, a coronary calcium scan also includes
visualization of the upper part of the liver. Despite this
being only a limited part of the whole liver, measurement
of the mean attenuation value at two or three locations –
which can readily be done using any CT-image viewer –
appears to reflect the total amount of fat in the liver [41,
42]. In turn, the amount of liver fat is regarded as an
important precursor of the metabolic syndrome, and is
related to both subclinical and clinical cardiovascular dis-
ease [43, 44]. Liver density may also reflect subclinical
hepatic fluid congestion and liver fat is associated with
adverse cardiac remodelling, both of which may herald
future heart failure [45].
Pulmonary artery diameter
The diameter of the pulmonary artery (Fig. 1, orange) can be
measured on non-contrast scans using any CT-image viewer
and may be considered as a marker of pulmonary arterial
pressure [46]. When adjusted for body size by comparison
to the aortic diameter in the same slice (i.e. the pulmonary-
artery-to-aorta ratio), increased pulmonary artery diameters
are related to risk of future adverse pulmonary events and
mortality, particularly in individuals with chronic obstructive
pulmonary disease [46, 47].
Beyond markers of cardio-metabolic health
In addition to aforementioned markers of cardio-metabolic
health, other structures that are imaged provide additional in-
formation on for example fracture risk and the presence or risk
of pulmonary events (Table 1).
Bone density
With regard to measuring the bone density (Fig.1, pink), it
should be acknowledged that apart from the heart, there may
be considerable variation in the imaged area, depending on
patient size and position. Yet, the majority of scans will in-
clude multiple thoracic vertebrae that can be assessed for bone
mineral density – a key modifiable risk factor for osteoporotic
Fig. 1 Imaging markers on non-
contrast coronary calcium scans.
Four slices of a coronary calcium
scan of a single patient showing
the heart at different levels with,
in colour, the different tissues
from which the potential imaging
markers may be obtained
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fractures [48, 49] – or the presence of vertebral osteoporotic
fractures [49].
Lung density
Measuring lung density (Fig. 1, dark blue) as a direct marker
of emphysema can be challenging, because in most clinical
settings the field-of-view is narrowly set to visualize coronary
calcium only [50]. Nonetheless, the overall lung density can
generally be measured in the lower lobes of the lungs and in
the areas surrounding the hila. However, it is important to
mention that apart from this dedicated, narrow field-of-view,
one may consider additionally reconstructing the coronary
calcium scan with a wider field-of-view to also visualize all
the lung tissue that was originally in the scan field. Although
the tops of the lungs will still be missing, one can obtain an
accurate impression of the status of the remaining part of the
lungs with respect to the amount of emphysema [51, 52]. A
downside of this wider field-of-view is the greater probability
of detecting incidental findings.
Incidental findings
When performing imaging, both in the clinical setting as well
as in the research setting, incidental findings can be expected.
However, the spectrum of potential incidental findings is rel-
atively limited for coronary calcium scans [53]. Apart from
cardiovascular abnormalities, incidental findings may espe-
cially be detected in the liver and the lungs. Given that no
contrast is administered during a coronary calcium scan, po-
tential findings in the liver are largely restricted to cystic le-
sions. However, for the lungs a substantial number of pulmo-
nary nodules may be expected. Especially for older individ-
uals and smokers, clear-cut criteria on the diagnostic work-up
of such pulmonary nodules have been established and refined
in the past decade [54, 55]. Other less frequent incidental
findings may include interstitial changes of the lung, pleural
effusion, chest wall abnormalities, breast calcifications and
mediastinal lymphadenopathy.
Radiation
A topic of concern accompanying the use of the coronary
calcium scan is the ionizing radiation exposure to the patient
or, in the research setting, to the study participant [56]. Two
general key principles that should always be kept in mind
when ordering a CT examination of any kind are justification
in ordering the examination and optimization of the scan pro-
tocol in the way that the radiation exposure is as-low-as-
reasonably-achievable (ALARA). With the newer generation
CT scanners and improvements in scan protocols, radiation
doses have been decreasing over the last few years and are
expected to decrease further with advances in technology [57].
Specifically for prospective ECG-gated non-contrast coronary
calcium scans, radiation exposure approximates 1.5 mSv (es-
timated using ImpactDose version 2.3, 2016, CT Imaging
GmbH, Erlangen, Germany) [58, 59]. For comparison, the
annual background radiation varies between 2 and 5 mSv.
Nonetheless, radiation exposure should always be weighed
against the information obtained from a coronary calcium
scan. Following the ALARA principle in minimizing radia-
tion exposure, it seems only reasonable to also force clinicians
and researchers to transpose this principle to data acquisition
once a scan is made: acquire asmuch as reasonably achievable
relevant information from every imaging study.
Conclusion
The clinical value of the CACS in terms of individual risk as-
sessment of future cardiac events has led to an increased use of
non-contrast cardiac CT in both clinical and research settings
during the past decades. Many other markers of cardio-
metabolic health and general health may readily be evaluated
on these examinations. Clinical cardiologists, cardiovascular ra-
diologists and medical specialists in the field of preventive med-
icine should be aware of this potential diagnostic and prognostic
extra-coronary yield of the coronary calcium scan, and widen
their professional field-of-view to look beyond the heart.
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